Dupilumab Studied in Patients Hospitalized for COVID-19
No difference seen between dupilumab and placebo groups in adverse events or primary outcome of ventilator-free survival at 28 days
Text Message Reminders Promote Receipt of Second Flu Shot
Text message reminders with embedded interactive educational information increase receipt, timeliness of second vaccine dose in children
Mepolizumab Cuts Exacerbations in Children With Severe Asthma
Trial enrolled children from disadvantaged urban neighborhoods who have exacerbation-prone eosinophilic asthma
Tabrecta Gains Full FDA Approval for Non-Small Cell Lung Cancer
Drug approved for non-small cell lung cancer with mutation leading to MET exon 14 skipping
U.K. Is First Country to Approve Moderna Omicron-Targeted Vaccine
Updated vaccine expected to have 'important role' in protecting people from COVID-19 this winter
Symptoms Linger for Some Children After Acute COVID-19, MIS-C
Persistent symptoms or activity impairment seen in more than 25 percent of children hospitalized with COVID-19, MIS-C
Most Women With Lung Cancer Report Sexual Dysfunction
Little or no interest in sexual activity reported by majority of patients surveyed
How Will New Federal Legislation Cut Drug Costs?
Under the law, Medicare will now be allowed to negotiate the cost of some drugs; vaccines will be free for Part D recipients
Survival Benefit Seen With Triple Therapy for Severe COVID-19
Compared with dual therapy, significant survival benefit seen with dexamethasone, remdesivir, and baricitinib but no change in length of stay
Burden of Disease Attributed to PFAS Exposure High in the U.S.
Estimated cost of PFAS-attributable disease at least $5.52 billion annually
